HDFC Defence Fund - Growth Option - Direct Plan vs HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
A side-by-side comparison of returns, cost, size and risk. Both funds sit in the same category, so these figures are directly comparable.
NAV as of 17 Aug 2026. Returns over 1 year are annualised. Past performance does not indicate future returns, and this comparison is not a recommendation.
| Metric | HDFC Defence Fund | HDFC Pharma and Healthcare Fund |
|---|---|---|
| Category | Sectoral/ Thematic | Sectoral/ Thematic |
| Fund house | HDFC Mutual Fund | HDFC Mutual Fund |
| NAV | ₹31.741 | ₹22.204 |
| 1Y return | +22.63% | +26.61% |
| 3Y return | +35.90% | +30.17% |
| 5Y return | — | — |
| AUM | ₹11,478 Cr | ₹3,311 Cr |
| Expense ratio | 0.91% | 1.03% |
| Risk | Very High | Very High |
Highlighting marks the higher return or lower cost on rows where both funds have data. It is arithmetic, not advice — a cheaper or higher-returning fund is not automatically the better choice for you.